scispace - formally typeset
A

Alan Ashworth

Researcher at University of California, San Francisco

Publications -  589
Citations -  82138

Alan Ashworth is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 134, co-authored 578 publications receiving 72089 citations. Previous affiliations of Alan Ashworth include Imperial College London & Papworth Hospital.

Papers
More filters
Journal ArticleDOI

Molecular genetic characterisation of frontotemporal dementia on chromosome 3.

TL;DR: A locus causing familial nonspecific dementia to the centromeric region of chromosome 3 in a pedigree from the Jutland area of Denmark shows anticipation which is suggestive of trinucleotide repeat expansion involvement, and strategies to clone the mutant gene via its putative associated trinuclear repeat sequence are outlined.
Journal ArticleDOI

Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

TL;DR: Both cross-sectional and longitudinal data analyses provided strong evidence for associations between changes in methylation levels and aging and support for the use of white blood cell DNA methylation as a biomarker of exposure in EWAS.
Journal ArticleDOI

The proteasome is involved in determining differential utilization of double-strand break repair pathways.

TL;DR: It is demonstrated that inhibition of proteasome proteolytic activity results in an increase in the utilization of potentially mutagenic single-strand annealing at the expense of a reduction in the level of error-free gene conversion, confirming a functional link between DSB repair and proteasomal activity.
Journal ArticleDOI

Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia

TL;DR: Interphase cytogenetics data provide evidence for the existence of a new tumor suppressor locus in B-cell CLL located at 13q12.3.
Posted ContentDOI

Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA

TL;DR: It is found that 5hmC sites are enriched in a disease and stage specific manner in exons, 3’UTRs and transcription termination sites with progressive disease suggesting increased transcriptional activity.